### The Seamless Link
This performance underscores a fundamental dichotomy in India's renewable energy manufacturing ambitions. While module assembly has scaled exponentially, the foundational solar cell production segment lags significantly, creating a persistent bottleneck that necessitates substantial overseas procurement.
### The Core Catalyst: The Cell Production Chasm
Despite adding a staggering 119 GW of solar module manufacturing capacity in 2025, India's cell production only grew by 9 GW, reaching approximately 27 GW. This leaves domestic cell capacity at just 15.3% of module capacity, forcing a reliance on 99 GW of imports for modules and cells, with cells constituting 75% of this volume. This reliance directly impacts cost structures, as India faces competitive pricing pressures from global leaders, particularly China, which dominates upstream polysilicon (93%), wafer (97%), and cell (85%) production. The ALMM List-II mandate, requiring domestic cells for government projects from June 2026, will further intensify pressure on this limited domestic supply, potentially inflating costs for utility-scale projects.
### The Analytical Deep Dive
India's ambition to rival China's solar supply chain dominance is ambitious but faces structural headwinds. While module capacity now stands around 210 GW, significantly exceeding domestic demand estimates of 40 GW, this overcapacity in modules is juxtaposed against an acute cell shortage. This asymmetry means that much of the expanded module capacity may still rely on imported cells, limiting true upstream integration. Companies like Waaree Energies are aggressively expanding, with Nuvama Institutional Equities maintaining a 'Buy' rating and a target price of ₹3,867, citing strong execution and expansion into cell manufacturing by September 2026. However, Waaree's cell capacity, while growing, is part of a sector where overall domestic cell production remains a fraction of module output. The sector is increasingly adopting advanced technologies like TOPCon and monocrystalline, with 70% of module capacity using TOPCon and over 57% of cell capacity using monocrystalline technology. However, the overall cost-competitiveness of 'Made in India' modules, especially when using imported cells, remains a challenge compared to fully imported Chinese products. Polysilicon prices, a key upstream component, have seen volatility but are projected to grow moderately, with global demand driven by solar and semiconductor sectors.
### The Forensic Bear Case
The most significant structural weakness is the profound deficit in solar cell manufacturing. With module capacity around 210 GW and cell capacity at 27 GW, the industry faces a critical dependence on imports to feed its own expanded assembly lines. This imbalance is exacerbated by the high concentration of cell manufacturing, where the top 10 players control 99.5% of capacity. Furthermore, India has virtually no presence in wafer and polysilicon production, making it vulnerable to global supply chain disruptions and price fluctuations, primarily dictated by China's market control. The country's exports, heavily reliant on the US market which took 96.8% of modules in 2025, are now vulnerable to escalating US tariffs (up to 50%) which have already led to a significant drop in shipments. This collapse of the primary export valve forces a strategic pivot, but diversification into the 'Global South' is a challenging endeavor against established Chinese competition. While the ALMM List-II mandate aims to boost domestic cell demand starting June 2026, it risks driving up costs and creating supply shortages for manufacturers dependent on imported cells. Structural dependence on imports implies historical execution challenges in upstream segments.
### The Future Outlook
The projected growth in India's solar manufacturing capacity, with module capacity potentially reaching 160 GW and cell capacity 120 GW by 2030, suggests a concerted effort to address the current deficit. However, achieving this scale requires not only investment but also overcoming significant technological and cost-competitiveness hurdles. Analyst firm Nuvama forecasts robust growth for companies like Waaree Energies, projecting significant revenue and EBITDA increases based on expansion pipelines. Yet, the industry as a whole faces a critical juncture: transitioning from capacity expansion driven by incentives and protective policies to achieving genuine cost-competitiveness and supply chain self-sufficiency. The success hinges on bridging the cell production gap and diversifying beyond protected domestic markets.